Low folate raises plasma homocysteine even with adequate vitamin B12.

The relationship between folate and homocysteine is anchored in the fundamental biochemistry of the one-carbon metabolism cycle. Evidence confirms that folate is an essential substrate for the methionine synthase reaction, and its absence is a primary driver of elevated homocysteine, independent of other nutrient levels.

Mechanistic role in remethylation

At the molecular level, folate (specifically as 5-methyltetrahydrofolate or 5-MTHF) serves as the ultimate methyl donor for the conversion of homocysteine into methionine. This reaction is catalyzed by the enzyme methionine synthase, which utilizes vitamin B12 as a transient intermediate carrier. While B12 is necessary to move the methyl group, the group itself must originate from the folate pool. If folate availability is low, the enzyme lacks the necessary substrate to complete the cycle. Consequently, homocysteine cannot be remethylated and instead accumulates within the cells before being released into the plasma.

Clinical evidence and effectiveness

Clinical data, including large-scale observational studies like NHANES and various intervention trials, demonstrate that folate status is a potent predictor of homocysteine levels. Meta-analyses of supplementation trials show that providing 0.5–5 mg of folic acid daily can reduce plasma homocysteine by approximately 25% in populations where B12 levels are adequate but folate is suboptimal. This highlights that B12 and folate are not interchangeable; the presence of sufficient B12 cannot overcome a shortage of the 5-MTHF substrate. In clinical practice, the presence of elevated homocysteine alongside normal methylmalonic acid (MMA) levels—a specific marker for B12 function—is often used to confirm that folate deficiency is the specific cause of hyperhomocysteinemia.

Bottom line

Folate is a mandatory requirement for the remethylation of homocysteine. Because it acts as the primary methyl group donor, low folate availability will consistently raise plasma homocysteine levels even in individuals with optimal Vitamin B12 status.